TY - JOUR T1 - The clinical outcomes and effectiveness of mHealth interventions for diabetes and hypertension: a systematic review and meta-analysis JF - medRxiv DO - 10.1101/2020.02.20.20025635 SP - 2020.02.20.20025635 AU - Yaqian Mao AU - Wei Lin AU - Junping Weng AU - Gang Chen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/23/2020.02.20.20025635.abstract N2 - Background With the development of technology, mobile health (mHealth) intervention has been proposed as a treatment strategy for chronic diseases that could improve the quality of chronic care and outcomes in some developed countries. However, the effectiveness of mHealth intervention in developing countries is not clear.Purpose A systematic review and meta-analysis was conducted to study the clinical outcomes and effectiveness of mHealth interventions for diabetes and hypertension in countries with different levels of economic development.Methods Pubmed, ResearchGate, Embase and Cochrane documents were searched by computer, and the retrieval period was from 2008 to June 2019. All studies were randomized controlled trials (RCTs) comparing mHealth treatments to other traditional treatments. Meta-analysis was conducted using stata software.Results 51 RCTs (N=13,054 participants) were eligible for this systematic review and meta-analysis. Compared with the usual care, the mHealth interventions yielded significant mean differences in clinical outcomes, and had a positive effect on countries at different levels of economic development. It is reassuring that we found mHealth interventions combined with human intelligence could significantly improve clinical outcomes more than mHealth interventions alone [WMD (95%Cl)=−6.75 (−9.98, −3.52)] VS [WMD (95%Cl)=−2.53 (−4.99, −0.07)]. The main secondary outcomes showed that mHealth interventions could also improve quality of life, satisfaction and self-efficacy, etc.Conclusion This review shown that mHealth interventions as a therapeutic strategy could improve the management of diabetes and hypertension in countries with different levels of economic development.What is already known about this subject?What is already known about this subject?With the development of technology, mobile health (mHealth) intervention has been proposed as a treatment strategy for chronic diseases that could improve the quality of chronic care in some developed countries.Nowdays, there are many mHealth products on the market, whether these mHealth products can improve the patient’s clinical results or improve the quality of life are still lack of research.What are the new findings?What are the new findings?mHealth interventions as a therapeutic strategy could improve the management of diabetes and hypertension in countries with different levels of economic development.mHealth interventions combined with human intelligence could significantly improve clinical outcomes more than mHealth interventions alone.How might these results change the focus of research or clinical practice?How might these results change the focus of research or clinical practice?mobile health (mHealth) intervention can as a treatment strategy for chronic diseases, especially in the undeveloped places.mHealth intervention treatments combined with special staff management (pharmacist, dietitian, specialist nurse and sports trainer) had more effective than mHealth interventions alone.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are included within the article ER -